AGP Executive Report
Last update: 8 hours agoEnergy Costs: Middle East conflict-driven disruption to oil supplies is keeping fuel and freight costs in focus, a risk for Israeli manufacturers and shippers as global finance chiefs meet in Bangkok. Pharmaceuticals: Teva shares climbed 4.7% after US approval of Weltruza, its monthly injectable schizophrenia treatment; the company has forecast peak annual sales of $1.5 billion to $2 billion. Shipping: ZIM raised its 2026 EBITDA guidance to $2.7 billion–$3 billion, signaling stronger earnings expectations despite regional shipping risks. Defense Exports: Israel opened its first national defense pavilion at Morocco’s airshow, highlighting expanding industry ties and a push into overseas markets. Food Industry: A Tel Aviv University study found Israeli food prices rose 19% over four years, intensifying pressure on households and the food sector. Transport Innovation: Israel launched its first hydrogen-powered bus, using Chinese fuel-cell technology.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.
Perspectify News
